Charts Newron Pharmaceuticals S.p.A. Deutsche Boerse AG
Stocks
NP5
IT0004147952
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.78 EUR | +7.62% |
|
+3.49% | -49.91% |
| 05-05 | Edison Is Not Overly Concerned About a Trial Suspension |  |
| 04-30 | US FDA Halts New Patient Enrollment at Newron's Phase 3 Trial for Schizophrenia Treatment | MT |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NWRN Stock
- NP5 Stock
- Charts Newron Pharmaceuticals S.p.A.
Select your edition
All financial news and data tailored to specific country editions
